GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering

Abstract Engineered epithelial cell sheets for clinical replacement of non-functional upper aerodigestive tract mucosa are regulated as medicinal products and should be manufactured to the standards of good manufacturing practice (GMP). The current gold standard for growth of epithelial cells for re...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Angela Tait, Toby Proctor, Nick J. I. Hamilton, Martin A. Birchall, Mark W. Lowdell
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8f2673ced80b44e8beb594861f87e6b8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8f2673ced80b44e8beb594861f87e6b8
record_format dspace
spelling oai:doaj.org-article:8f2673ced80b44e8beb594861f87e6b82021-12-02T17:52:31ZGMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering10.1038/s41598-021-91939-02045-2322https://doaj.org/article/8f2673ced80b44e8beb594861f87e6b82021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91939-0https://doaj.org/toc/2045-2322Abstract Engineered epithelial cell sheets for clinical replacement of non-functional upper aerodigestive tract mucosa are regulated as medicinal products and should be manufactured to the standards of good manufacturing practice (GMP). The current gold standard for growth of epithelial cells for research utilises growth arrested murine 3T3 J2 feeder layers, which are not available for use as a GMP compliant raw material. Using porcine mucosal tissue, we demonstrate a new method for obtaining and growing non-keratinised squamous epithelial cells and fibroblast cells from a single biopsy, replacing the 3T3 J2 with a growth arrested primary fibroblast feeder layer and using pooled Human Platelet lysate (HPL) as the media serum supplement to replace foetal bovine serum (FBS). The initial isolation of the cells was semi-automated using an Octodissociator and the resultant cell suspension cryopreservation for future use. When compared to the gold standard of 3T3 J2 and FBS containing medium there was no reduction in growth, viability, stem cell population or ability to differentiate to mature epithelial cells. Furthermore, this method was replicated with Human buccal tissue, providing cells of sufficient quality and number to create a tissue engineered sheet.Angela TaitToby ProctorNick J. I. HamiltonMartin A. BirchallMark W. LowdellNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Angela Tait
Toby Proctor
Nick J. I. Hamilton
Martin A. Birchall
Mark W. Lowdell
GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
description Abstract Engineered epithelial cell sheets for clinical replacement of non-functional upper aerodigestive tract mucosa are regulated as medicinal products and should be manufactured to the standards of good manufacturing practice (GMP). The current gold standard for growth of epithelial cells for research utilises growth arrested murine 3T3 J2 feeder layers, which are not available for use as a GMP compliant raw material. Using porcine mucosal tissue, we demonstrate a new method for obtaining and growing non-keratinised squamous epithelial cells and fibroblast cells from a single biopsy, replacing the 3T3 J2 with a growth arrested primary fibroblast feeder layer and using pooled Human Platelet lysate (HPL) as the media serum supplement to replace foetal bovine serum (FBS). The initial isolation of the cells was semi-automated using an Octodissociator and the resultant cell suspension cryopreservation for future use. When compared to the gold standard of 3T3 J2 and FBS containing medium there was no reduction in growth, viability, stem cell population or ability to differentiate to mature epithelial cells. Furthermore, this method was replicated with Human buccal tissue, providing cells of sufficient quality and number to create a tissue engineered sheet.
format article
author Angela Tait
Toby Proctor
Nick J. I. Hamilton
Martin A. Birchall
Mark W. Lowdell
author_facet Angela Tait
Toby Proctor
Nick J. I. Hamilton
Martin A. Birchall
Mark W. Lowdell
author_sort Angela Tait
title GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
title_short GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
title_full GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
title_fullStr GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
title_full_unstemmed GMP compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
title_sort gmp compliant isolation of mucosal epithelial cells and fibroblasts from biopsy samples for clinical tissue engineering
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/8f2673ced80b44e8beb594861f87e6b8
work_keys_str_mv AT angelatait gmpcompliantisolationofmucosalepithelialcellsandfibroblastsfrombiopsysamplesforclinicaltissueengineering
AT tobyproctor gmpcompliantisolationofmucosalepithelialcellsandfibroblastsfrombiopsysamplesforclinicaltissueengineering
AT nickjihamilton gmpcompliantisolationofmucosalepithelialcellsandfibroblastsfrombiopsysamplesforclinicaltissueengineering
AT martinabirchall gmpcompliantisolationofmucosalepithelialcellsandfibroblastsfrombiopsysamplesforclinicaltissueengineering
AT markwlowdell gmpcompliantisolationofmucosalepithelialcellsandfibroblastsfrombiopsysamplesforclinicaltissueengineering
_version_ 1718379178911334400